Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
22
INMD Quote, Financials, Valuation and Earnings
Last price:
$14.49
Seasonality move
:
-12.07%
Day range:
$14.34 - $14.52
52-week range:
$13.14 - $19.78
Dividend yield:
0%
P/E ratio:
6.69x
P/S ratio:
2.68x
P/B ratio:
1.40x
Volume:
213.9K
Avg. volume:
546.2K
1-year change:
-15.18%
Market cap:
$914.6M
Revenue:
$394.8M
EPS (TTM):
$2.16
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
INMD
InMode Ltd.
|
$90.9M | $0.35 | 6.94% | -63.36% | $16.60 |
|
CATX
Perspective Therapeutics, Inc.
|
$206.8K | -$0.32 | -9.65% | -37.91% | $12.3077 |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$715.6K | -$0.05 | 272.5% | -33.67% | $2.20 |
|
VTAK
Catheter Precision, Inc.
|
$310K | -$0.20 | 118.75% | -11.57% | -- |
|
XTNT
Xtant Medical Holdings, Inc.
|
$32.7M | -- | -2.42% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
INMD
InMode Ltd.
|
$14.47 | $16.60 | $914.6M | 6.69x | $0.00 | 0% | 2.68x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.8150 | $12.3077 | $209.3M | -- | $0.00 | 0% | 190.87x |
|
PMI
Picard Medical
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
VNRX
VolitionRX Ltd.
|
$0.25 | $2.20 | $30.9M | -- | $0.00 | 0% | 17.27x |
|
VTAK
Catheter Precision, Inc.
|
$1.78 | -- | $2.2M | 0.40x | $0.00 | 0% | 8.37x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.78 | $1.50 | $108.9M | 76.27x | $0.00 | 0% | 0.85x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
INMD
InMode Ltd.
|
0.85% | 1.041 | 0.59% | 8.35x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.691 | 1.3% | 8.47x |
|
PMI
Picard Medical
|
-- | 0.000 | -- | -- |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.566 | 15.4% | 0.04x |
|
VTAK
Catheter Precision, Inc.
|
68.63% | -0.348 | 537.37% | 0.41x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 2.955 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
INMD
InMode Ltd.
|
$72.3M | $20.9M | 22.18% | 22.38% | 22.43% | $27M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
VTAK
Catheter Precision, Inc.
|
-$320K | -$3M | -79.27% | -192.05% | -1336.73% | -$2.2M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
InMode Ltd. vs. Competitors
-
Which has Higher Returns INMD or CATX?
Perspective Therapeutics, Inc. has a net margin of 23.47% compared to InMode Ltd.'s net margin of -12425.36%. InMode Ltd.'s return on equity of 22.38% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital INMDInMode Ltd.77.61% $0.34 $659M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About INMD or CATX?
InMode Ltd. has a consensus price target of $16.60, signalling upside risk potential of 14.72%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 349.19%. Given that Perspective Therapeutics, Inc. has higher upside potential than InMode Ltd., analysts believe Perspective Therapeutics, Inc. is more attractive than InMode Ltd..
Company Buy Ratings Hold Ratings Sell Ratings INMDInMode Ltd.0 6 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is INMD or CATX More Risky?
InMode Ltd. has a beta of 2.144, which suggesting that the stock is 114.37% more volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.
-
Which is a Better Dividend Stock INMD or CATX?
InMode Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InMode Ltd. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INMD or CATX?
InMode Ltd. quarterly revenues are $93.2M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. InMode Ltd.'s net income of $21.9M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, InMode Ltd.'s price-to-earnings ratio is 6.69x while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InMode Ltd. is 2.68x versus 190.87x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INMDInMode Ltd.2.68x 6.69x $93.2M $21.9M CATXPerspective Therapeutics, Inc.190.87x -- $209K -$26M
-
Which has Higher Returns INMD or PMI?
Picard Medical has a net margin of 23.47% compared to InMode Ltd.'s net margin of --. InMode Ltd.'s return on equity of 22.38% beat Picard Medical's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital INMDInMode Ltd.77.61% $0.34 $659M PMIPicard Medical-- -- -- -
What do Analysts Say About INMD or PMI?
InMode Ltd. has a consensus price target of $16.60, signalling upside risk potential of 14.72%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that InMode Ltd. has higher upside potential than Picard Medical, analysts believe InMode Ltd. is more attractive than Picard Medical.
Company Buy Ratings Hold Ratings Sell Ratings INMDInMode Ltd.0 6 0 PMIPicard Medical0 0 0 -
Is INMD or PMI More Risky?
InMode Ltd. has a beta of 2.144, which suggesting that the stock is 114.37% more volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock INMD or PMI?
InMode Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InMode Ltd. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INMD or PMI?
InMode Ltd. quarterly revenues are $93.2M, which are larger than Picard Medical quarterly revenues of --. InMode Ltd.'s net income of $21.9M is higher than Picard Medical's net income of --. Notably, InMode Ltd.'s price-to-earnings ratio is 6.69x while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InMode Ltd. is 2.68x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INMDInMode Ltd.2.68x 6.69x $93.2M $21.9M PMIPicard Medical-- -- -- --
-
Which has Higher Returns INMD or VNRX?
VolitionRX Ltd. has a net margin of 23.47% compared to InMode Ltd.'s net margin of -862.39%. InMode Ltd.'s return on equity of 22.38% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital INMDInMode Ltd.77.61% $0.34 $659M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About INMD or VNRX?
InMode Ltd. has a consensus price target of $16.60, signalling upside risk potential of 14.72%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 773.02%. Given that VolitionRX Ltd. has higher upside potential than InMode Ltd., analysts believe VolitionRX Ltd. is more attractive than InMode Ltd..
Company Buy Ratings Hold Ratings Sell Ratings INMDInMode Ltd.0 6 0 VNRXVolitionRX Ltd.4 2 0 -
Is INMD or VNRX More Risky?
InMode Ltd. has a beta of 2.144, which suggesting that the stock is 114.37% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.
-
Which is a Better Dividend Stock INMD or VNRX?
InMode Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InMode Ltd. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INMD or VNRX?
InMode Ltd. quarterly revenues are $93.2M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. InMode Ltd.'s net income of $21.9M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, InMode Ltd.'s price-to-earnings ratio is 6.69x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InMode Ltd. is 2.68x versus 17.27x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INMDInMode Ltd.2.68x 6.69x $93.2M $21.9M VNRXVolitionRX Ltd.17.27x -- $627.3K -$5.4M
-
Which has Higher Returns INMD or VTAK?
Catheter Precision, Inc. has a net margin of 23.47% compared to InMode Ltd.'s net margin of -1037.17%. InMode Ltd.'s return on equity of 22.38% beat Catheter Precision, Inc.'s return on equity of -192.05%.
Company Gross Margin Earnings Per Share Invested Capital INMDInMode Ltd.77.61% $0.34 $659M VTAKCatheter Precision, Inc.-141.59% -$1.70 $21.3M -
What do Analysts Say About INMD or VTAK?
InMode Ltd. has a consensus price target of $16.60, signalling upside risk potential of 14.72%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 2034.9%. Given that Catheter Precision, Inc. has higher upside potential than InMode Ltd., analysts believe Catheter Precision, Inc. is more attractive than InMode Ltd..
Company Buy Ratings Hold Ratings Sell Ratings INMDInMode Ltd.0 6 0 VTAKCatheter Precision, Inc.0 0 0 -
Is INMD or VTAK More Risky?
InMode Ltd. has a beta of 2.144, which suggesting that the stock is 114.37% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.
-
Which is a Better Dividend Stock INMD or VTAK?
InMode Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InMode Ltd. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INMD or VTAK?
InMode Ltd. quarterly revenues are $93.2M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. InMode Ltd.'s net income of $21.9M is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, InMode Ltd.'s price-to-earnings ratio is 6.69x while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InMode Ltd. is 2.68x versus 8.37x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INMDInMode Ltd.2.68x 6.69x $93.2M $21.9M VTAKCatheter Precision, Inc.8.37x 0.40x $226K -$2.3M
-
Which has Higher Returns INMD or XTNT?
Xtant Medical Holdings, Inc. has a net margin of 23.47% compared to InMode Ltd.'s net margin of 3.93%. InMode Ltd.'s return on equity of 22.38% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital INMDInMode Ltd.77.61% $0.34 $659M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About INMD or XTNT?
InMode Ltd. has a consensus price target of $16.60, signalling upside risk potential of 14.72%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 92.8%. Given that Xtant Medical Holdings, Inc. has higher upside potential than InMode Ltd., analysts believe Xtant Medical Holdings, Inc. is more attractive than InMode Ltd..
Company Buy Ratings Hold Ratings Sell Ratings INMDInMode Ltd.0 6 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is INMD or XTNT More Risky?
InMode Ltd. has a beta of 2.144, which suggesting that the stock is 114.37% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.
-
Which is a Better Dividend Stock INMD or XTNT?
InMode Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InMode Ltd. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INMD or XTNT?
InMode Ltd. quarterly revenues are $93.2M, which are larger than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. InMode Ltd.'s net income of $21.9M is higher than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, InMode Ltd.'s price-to-earnings ratio is 6.69x while Xtant Medical Holdings, Inc.'s PE ratio is 76.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InMode Ltd. is 2.68x versus 0.85x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INMDInMode Ltd.2.68x 6.69x $93.2M $21.9M XTNTXtant Medical Holdings, Inc.0.85x 76.27x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
